Physician
Hematology Oncology Associates of Brooklyn, LLP
Hematology Oncology Associates of Brooklyn, LLP was paid $291K by Medicaid between Jan 2018 and Nov 2024, across 12 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.
33Billing provider infoHEMATOLOGY ONCOLOGY ASSOCIATES OF BROOKLYN, LLP
BROOKLYN, NY 11229
BROOKLYN, NY 11229
33aNPI1437124682assigned 02/21/2006
33bProvider typeHematology & Oncology Physician
28Total paid$291K
24GClaims19,450
24DCodes billed12
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in New York
Rank by total paid#40 of 441
Median peer was paid$9K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 695 | $5K | |
| 2019 | 1,630 | $19K | |
| 2020 | 1,941 | $21K | |
| 2021 | 3,418 | $37K | |
| 2022 | 5,291 | $88K | |
| 2023 | 4,134 | $91K | |
| 2024incomplete | 2,341 | $31K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 45% | 1,670 | 1,660 | $132K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 15% | 52 | 40 | $44K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 12% | 9,241 | 7,139 | $35K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.3% | 407 | 404 | $27K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 8.0% | 432 | 337 | $23K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.5% | 154 | 154 | $19K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.2% | 261 | 201 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,662 | 5,772 | $2K |
| 96367 | <1% | 66 | 48 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 244 | 155 | $2K |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 248 | 209 | $2K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 13 | 12 | $26.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOSHEL, ABE (ADMINISTRATOR)